Virtual Clinical Trials
Focused on Patient-Centricity by Delivering Clinical Trials Directly to Patients
We understand how challenging it is to adopt a novel approach to drug development. Pivoting to virtual clinical trials is no exception.
The focus on delivering patient-centric practices to improve clinical trial participation by reducing the burden on patients is the cornerstone of clinical research excellence. Over the last few years, there has been a shift to bring the clinical trial to the patient’s home, an evident disruption of historical clinical trial conduct practices. While adoption has not been widespread, the COVID-19 pandemic has rapidly turned this ideology into a necessary reality.
The time for decentralized and virtual trial adoption is now. A flexible clinical trial approach is the solution.
Solving Challenges with a Virtual Clinical Trial Approach
The Veristat virtual clinical trial approach is both flexible and customizable to the needs of each patient and trial design. For example, traditional on-site activities such as dosing, lab work, and follow-up can be conducted remotely at home or through a hybrid model that combines both on-site and at-home visits. In some cases, the investigational product (IP) may be shipped directly to the patient or brought to the patient by a traveling nurse. In other situations, nurses conduct at-home visits to dose patients. They also collect demographic information, vitals, and perform simple lab work.
The virtual trial model solves many significant challenges facing drug developers today:
- Improving patient recruitment and retention for trials by reducing the patient burden of travel and time going to physical sites
- Finding the right patients by removing geographic barriers to patient eligibility
- Offering a flexible and fully integrated hybrid site model customized to the comfort levels of the patients, sites, sponsors, etc.
- Overcoming COVID-19 restrictions and restoring continuity of new and ongoing clinical trials regardless of future restrictions
The time for virtual clinical trial adoption is now. Our flexible virtual trials approach eases the burden of clinical trial participation on the patients, allows trials stalled by COVID-19 to move forward, and improves overall clinical trial conduct efficiency.
Executive Vice President, Global Clinical Operations, Veristat
How to Make a Virtual Trial Toolbox Work?
A virtual clinical trial is more complicated than sending a traveling nurse to visit a patient at their home. Our comprehensive and full-service approach to virtual clinical trial conduct integrates all the processes and technologies necessary for success. We coordinate all communication channels between patients, sites, nurses, labs, and trial monitors.
Establish Digital Patient Recruitment/Retention Methodologies
- Developing digital marketing and branding strategies for patient recruitment and education
- Mobilizing physician-staffed call center to qualify and register patients
- Managing communication channels between the site, at-home nurse, patient, and other integrated vendors/technologies
Deploy At-Home Patient Visits
- Performing study protocol requirements by traveling nurses. A nurse conducts the at-home patient visits as outlined by the study protocol
- Managing logistics differently - Proven logistics management such as sending supplies to the patient instead of site, facilitating lab work, etc.
- Collecting source data at home
Launch Virtual Patient Interactions
- Connecting patients and treating physicians through Telemedicine (video meetings)
- Utilizing ePRO, eSource, and eConsent capabilities that integrate with EDC
- Monitoring traditional sites and virtual sites remotely
Is a Virtual Clinical Trial Approach Right for You?
We understand how challenging it is to adopt a new way of conducting clinical trials. Pivoting to virtual clinical trials is no exception. We have the agility and scientific-minded experts to help you navigate this novel approach to clinical development.
With virtual trials running right now, we have designed a customized virtual trial ecosystem to satisfy both the study and patients' needs.